Never share an injection pen, cartridge, or syringe with another person, even if the needle has been changed
there are no Food and Drug Administration-approved therapies available for the treatment of this disease
In the SURMOUNT-1 study, a phase 3 clinical trial in obese patients, randomized participants in a 1:1:1:1 ratio to tirzepatide (5, 10, 15 mg) or placebo over 72 weeks, significant weight reductions were observed at 72 weeks: 15.0% for 5 mg, 19.5% for 10 mg, 20.9% for 15 mg, compared to 3.1% for placebo [18]
During GLP-1RA therapy, sustained hypophagia may further reduce effective micronutrient intake without immediately producing overt deficiency
Research has explored effects on cortisol release, neurotransmitter levels including serotonin and GABA, and autonomic nervous system tone
For researchers who need to establish long-term supply, Loti Labs offers flexible ordering options and can accommodate bulk orders for extended research programs